BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 24948399)

  • 21. The roles of retinoic acid and retinoic acid receptors in inducing epigenetic changes.
    Urvalek A; Laursen KB; Gudas LJ
    Subcell Biochem; 2014; 70():129-49. PubMed ID: 24962884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA Methylation and Non-Coding RNAs during Tissue-Injury Associated Pain.
    Irfan J; Febrianto MR; Sharma A; Rose T; Mahmudzade Y; Di Giovanni S; Nagy I; Torres-Perez JV
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic regulation and chromatin remodeling in learning and memory.
    Kim S; Kaang BK
    Exp Mol Med; 2017 Jan; 49(1):e281. PubMed ID: 28082740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global epigenetic profiling in bladder cancer.
    Dudziec E; Goepel JR; Catto JW
    Epigenomics; 2011 Feb; 3(1):35-45. PubMed ID: 22126151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications.
    Inoue F; Sone K; Toyohara Y; Takahashi Y; Kukita A; Hara A; Taguchi A; Tanikawa M; Tsuruga T; Osuga Y
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switching on epigenetic therapy.
    Karberg S
    Cell; 2009 Dec; 139(6):1029-31. PubMed ID: 20005793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation in cell senescence.
    Cheng LQ; Zhang ZQ; Chen HZ; Liu DP
    J Mol Med (Berl); 2017 Dec; 95(12):1257-1268. PubMed ID: 28887637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer.
    Xiao Y; Su M; Ou W; Wang H; Tian B; Ma J; Tang J; Wu J; Wu Z; Wang W; Zhou Y
    Biomed Pharmacother; 2019 Sep; 117():109192. PubMed ID: 31387188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Potential epigenetic therapeutics for atherosclerosis treatment.
    Nicorescu I; Dallinga GM; de Winther MPJ; Stroes ESG; Bahjat M
    Atherosclerosis; 2019 Feb; 281():189-197. PubMed ID: 30340764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.
    Ramakrishnan S; Pili R
    Cancer J; 2013; 19(4):333-40. PubMed ID: 23867515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic Regulation of Vascular Diseases.
    Zarzour A; Kim HW; Weintraub NL
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):984-990. PubMed ID: 31070469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trials with 'epigenetic' drugs: an update.
    Nebbioso A; Carafa V; Benedetti R; Altucci L
    Mol Oncol; 2012 Dec; 6(6):657-82. PubMed ID: 23103179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and epigenetic underpinnings of sex differences in the brain and in neurological and psychiatric disease susceptibility.
    Qureshi IA; Mehler MF
    Prog Brain Res; 2010; 186():77-95. PubMed ID: 21094887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetics in rheumatoid arthritis.
    Trenkmann M; Brock M; Ospelt C; Gay S
    Clin Rev Allergy Immunol; 2010 Aug; 39(1):10-9. PubMed ID: 19707891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decoding liver injury: A regulatory role for histone modifications.
    Tian W; Xu Y
    Int J Biochem Cell Biol; 2015 Oct; 67():188-93. PubMed ID: 25801055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigenetic programming and risk: the birthplace of cardiovascular disease?
    Vinci MC; Polvani G; Pesce M
    Stem Cell Rev Rep; 2013 Jun; 9(3):241-53. PubMed ID: 22773406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic regulation of CC-chemokine ligand 2 in nonresolving inflammation.
    Kiguchi N; Saika F; Kobayashi Y; Kishioka S
    Biomol Concepts; 2014 Aug; 5(4):265-73. PubMed ID: 25372758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic Modifications in Cardiovascular Aging and Diseases.
    Zhang W; Song M; Qu J; Liu GH
    Circ Res; 2018 Sep; 123(7):773-786. PubMed ID: 30355081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic targeting for acute kidney injury.
    Zhuang S
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():21-25. PubMed ID: 30298650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.